TimepointDx

📍 Basking Ridge, United States🗓 Founded 2025👥 1 employees💰 Last funded 2025
Biotechnology Research🌐 timepointdx.com
Website LinkedIn
TimepointDx is engaged patient-centric blood sampling via novel capillary blood collection technologies for downstream translational discovery, exploratory biomarkers and diagnostics operations in pharmaceutical clinical trials and research. As pioneers of Longitudinal Capillary Multiomics™ (LCM™), TimepointDx enables robust longitudinal multiomics (genomics, transcriptomics, and proteomics) as standard of practice for clinical trials. LCM™ enables standardized and harmonized longitudinal capillary multiomics to create rich biomarker stories of clinical trial participants. TimepointDx is also pioneering novel technologies, including Aggregated Longitudinal Sequencing™ (ALseq™) for cost-effective WGS + WES and Capillary Stem Cell Reprogramming™ (CSCR™) for patient-specific iPSCs in vitro disease modeling. Learn more at www.timepointdx.com
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in TimepointDx?
TimepointDx has 1 investors on record on gritt.io, including 1 early-stage backers.
When did TimepointDx last raise funding?
The most recent investment in TimepointDx recorded on gritt.io was in 2025.
When was TimepointDx founded?
TimepointDx was founded in 2025.
What industry is TimepointDx in?
TimepointDx operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TimepointDx based?
TimepointDx is headquartered in Basking Ridge, United States.